Our Corporate Partners

The International PNH Interest Group is a recognized by the US Internal Revenue Service as a not-for-profit organization. We are grateful to our Corporate Partners, who support our work.

Platinum Partners

Alexion Pharmaceuticals


Regeneron Pharmaceuticals, Inc.


F. Hoffmann-La-Roche


Gold Partner

Silver Partners

Apellis Pharmaceuticals, Inc.


Omeros Corporation


Bronze Partners

Kira Pharmaceuticals


If you have questions about or are interested in becoming a corporate partner and supporting our work, please contact us. Corporate membership is open to pharmaceutical and biotechnology companies interested or engaged in PNH research.

Representatives from investment and venture capital firms are not eligible for membership, given that IPIG is a not-for-profit scientific/educational organization whose purpose is to promulgate knowledge about and advocate for appropriate treatment and care of persons living with PNH.

Become a member

If you are a clinician, academic, and/or researcher involved or interested in PNH research or care and are not currently an IPIG member, please considering applying for membership. There are no joining fees or membership dues. Learn more on our membership page and/or email your membership questions to [email protected]

Apply for membership